Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued

SIMPLE SUMMARY: Cancer-associated thrombosis is a frequent complication and a poor prognostic event. Bevacizumab is an antiangiogenic drug used in the treatment of many cancers. Few data are available on the concomitant use of bevacizumab and anticoagulant therapy. The aim of this retrospective mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayenga, Marie, Falvo, Nicolas, Mahé, Isabelle, Jannot, Anne-Sophie, Gazeau, Benoit, Meyer, Guy, Gendron, Nicolas, Sanchez, Olivier, Djennaoui, Sadji, Planquette, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417508/
https://www.ncbi.nlm.nih.gov/pubmed/37568708
http://dx.doi.org/10.3390/cancers15153893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417508/
https://www.ncbi.nlm.nih.gov/pubmed/37568708
http://dx.doi.org/10.3390/cancers15153893

Ejemplares similares